Bionomics Investor Presentation Deck
Powered by a Seasoned and Experienced Management Team
Archemix
*AVE
Aventis
BIODEL
Bionomics
Errol De Souza, PhD
Executive Chairman
Liz Doolin
VP Clinical Development
CATALYST
BIOSCIENCES
cyclerion
Circumvent
Pharma
Deloitte.
1. Logos reflect experience in current and/or past roles.
DUPONT
IDEXX
LABORATORIES
LINK
IMMUNOTHERAPEUTICS
18
Connor Bernstein
VP Strategy, Corporate
Development & IR
Adrian Hinton
Interim Chief Financial
Officer
Neurocrine
BIOSCIENCES
NEUROPORE
THERAPIESINE
PALATIN
PIPER SANDLER
ROYALTY PHARMA
RBC Capital Markets
RBC
Synaptic p
Tharma Ltd.
BOARD OF DIRECTORS ¹ 1
11
Errol De Souza PhD
Executive Chairman
David Wilson
Non-Executive Director
Alan Fisher
Non-Executive Director
Jane Ryan PhD
Non-Executive Director
Aaron Weaver
Apeiron Nominee
Miles Davies
Apeiron Nominee
Bionomics
&Lybrand
27
WGpartners
PiperJaffray.
3
ALLIANCE
australaimited
CENTREPOINT
ANATARA
LIFESCIENCES
BCAL diagnostics
at blidering for every women, eserywbem.
APEIRON
INVESTMENT GROUP
atai A&O
LIFE SCIENCES
APEIRON
INVESTMENT GROUP
Rothschild & CoView entire presentation